D. Alberti

1.0k total citations
26 papers, 777 citations indexed

About

D. Alberti is a scholar working on Genetics, Hematology and Nephrology. According to data from OpenAlex, D. Alberti has authored 26 papers receiving a total of 777 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Genetics, 10 papers in Hematology and 7 papers in Nephrology. Recurrent topics in D. Alberti's work include Hemoglobinopathies and Related Disorders (10 papers), Iron Metabolism and Disorders (7 papers) and Dialysis and Renal Disease Management (5 papers). D. Alberti is often cited by papers focused on Hemoglobinopathies and Related Disorders (10 papers), Iron Metabolism and Disorders (7 papers) and Dialysis and Renal Disease Management (5 papers). D. Alberti collaborates with scholars based in Italy, Switzerland and United States. D. Alberti's co-authors include Francesco Locatelli, B Redaelli, A Giangrande, G. Graziani, G. Buccianti, Daniele Marcelli, Mario Comelli, Gianni Tognoni, Rosa Arboretti and Claudio Ponticelli and has published in prestigious journals such as The Lancet, Blood and American Journal of Epidemiology.

In The Last Decade

D. Alberti

25 papers receiving 736 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. Alberti Italy 13 330 234 207 192 118 26 777
Giovanni Manca Rizza Italy 9 398 1.2× 165 0.7× 45 0.2× 59 0.3× 37 0.3× 11 639
H. A. Bock Switzerland 15 237 0.7× 101 0.4× 29 0.1× 166 0.9× 75 0.6× 28 748
Charles J. Kaupke United States 14 218 0.7× 328 1.4× 142 0.7× 60 0.3× 19 0.2× 26 652
N.D. Vaziri United States 14 210 0.6× 158 0.7× 60 0.3× 28 0.1× 78 0.7× 30 525
Sabrina Paoletti Italy 14 392 1.2× 162 0.7× 51 0.2× 55 0.3× 29 0.2× 19 628
Mauro Sasdelli Italy 9 947 2.9× 81 0.3× 120 0.6× 166 0.9× 60 0.5× 13 1.1k
A. J. W. Branten Netherlands 18 696 2.1× 65 0.3× 52 0.3× 136 0.7× 69 0.6× 26 1.1k
Soichiro Iimori Japan 16 418 1.3× 103 0.4× 45 0.2× 48 0.3× 38 0.3× 41 757
Hideki Yamaya Japan 12 158 0.5× 266 1.1× 188 0.9× 36 0.2× 63 0.5× 28 625
Beth A. Vogt United States 12 178 0.5× 113 0.5× 62 0.3× 69 0.4× 19 0.2× 22 617

Countries citing papers authored by D. Alberti

Since Specialization
Citations

This map shows the geographic impact of D. Alberti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Alberti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Alberti more than expected).

Fields of papers citing papers by D. Alberti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Alberti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Alberti. The network helps show where D. Alberti may publish in the future.

Co-authorship network of co-authors of D. Alberti

This figure shows the co-authorship network connecting the top 25 collaborators of D. Alberti. A scholar is included among the top collaborators of D. Alberti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Alberti. D. Alberti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Gattermann, Norbert, N. Zoumbos, Emanuele Angelucci, et al.. (2006). Impact on Iron Removal of Dose Reduction for Non-Progressive Serum Creatinine Increases during Treatment with the Once-Daily, Oral Iron Chelator Deferasirox (Exjade®, ICL670).. Blood. 108(11). 3824–3824. 7 indexed citations
3.
Grottoli, Silvia, Valentina Gasco, Rosario Pivonello, et al.. (2005). Efficacy and safety of 48 weeks of treatment with octreotide LAR in newly diagnosed acromegalic patients with macroadenomas: An open-label, multicenter, non-comparative study. Journal of Endocrinological Investigation. 28(2). 978–983. 17 indexed citations
6.
Thomas, Merlin C., Con Tsalamandris, Richard J. MacIsaac, et al.. (2004). Low-molecular-weight AGEs are associated with GFR and anemia in patients with type 2 diabetes. Kidney International. 66(3). 1167–1172. 59 indexed citations
7.
Rosti, Gianantonio, Elena Trabacchi, Sebastián Bassi, et al.. (2003). Risk and early cytogenetic response to imatinib and interferon in chronic myeloid leukemia.. PubMed. 88(3). 256–9. 20 indexed citations
8.
Arboretti, Rosa, Gianni Tognoni, & D. Alberti. (2001). Pharmacosurveillance and quality of care of thalassaemic patients. European Journal of Clinical Pharmacology. 56(12). 915–922. 47 indexed citations
9.
Maschio, Giuseppe, D. Alberti, Francesco Locatelli, et al.. (1999). Angiotensin-Converting Enzyme Inhibitors and Kidney Protection: The AIPRI Trial. Journal of Cardiovascular Pharmacology. 33. S16–S20. 58 indexed citations
10.
Porter, John B., D. Alberti, Iman Hassan, et al.. (1998). Phase I, single dose trial on depot desferrioxamine (CGH 749B) in transfusion-dependent beta-thalassemic patients. UCL Discovery (University College London). 1 indexed citations
11.
Locatelli, Francesco, G Maschio, Johannes F.E. Mann, et al.. (1997). Long-term progression of chronic renal insufficiency in the AIPRI extension study. Kidney International. 51(63). 21 indexed citations
12.
Locatelli, Francesco, Daniele Marcelli, Mario Comelli, et al.. (1996). Proteinuria and blood pressure as causal components of progression to end-stage renal failure. Nephrology Dialysis Transplantation. 11(3). 461–467. 134 indexed citations
13.
Marcelli, Daniele, Francesco Locatelli, D. Alberti, et al.. (1995). Hypertension as a factor in chronic renal insufficiency progression in polycystic kidney disease. Nephrology Dialysis Transplantation. 10(supp6). 15–17. 19 indexed citations
14.
Locatelli, Francesco, D. Alberti, G. Graziani, et al.. (1992). Factors affecting chronic renal failure progression: results from a multicentre trial. The Northern Italian Cooperative Study Group.. PubMed. 18(2-5). 295–302. 21 indexed citations
15.
Locatelli, Francesco, D. Alberti, G. Graziani, et al.. (1991). Prospective, randomised, multicentre trial of effect of protein restriction on progression of chronic renal insufficiency. The Lancet. 337(8753). 1299–1304. 162 indexed citations
16.
Alberti, D., et al.. (1991). [Effects of benazepril, a new ACE inhibitor, in effort angina pectoris].. PubMed. 36(10). 785–92. 1 indexed citations
17.
Caponnetto, S, E. Valvo, Paolo Mocarelli, D. Alberti, & Stefano Savonitto. (1991). Cadralazine versus prazosin as second-step treatment in hypertensive patients on beta-blockers: a randomized multicentre study. European Journal of Clinical Pharmacology. 40(5). 461–465.
18.
Bichisao, E., Laura Merlini, Orsola Gambini, D. Alberti, & G Pollavini. (1989). Chlorthalidone Alone or in Fixed Combination with Slow-Release Metoprolol in the Management of Arterial Hypertension: A Long-Term Study of 545 Patients. Journal of International Medical Research. 17(4). 339–349. 3 indexed citations
19.
Radice, M, D. Alberti, C Alli, et al.. (1986). ACCURACY OF THE ANAMNESTIC ASCERTAINMENT OF PARENTAL HISTORY OF HYPERTENSION1. American Journal of Epidemiology. 124(2). 332–333. 3 indexed citations
20.
Radice, M, D. Alberti, C Alli, et al.. (1984). [Efficacy of screening for arterial hypertension in an adult population].. PubMed. 29(11). 523–7. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026